XNASHCTI
Market cap4mUSD
Dec 24, Last price
0.73USD
1D
-5.93%
1Q
73.04%
IPO
-97.96%
Name
Healthcare Triangle Inc
Chart & Performance
Profile
Healthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services. It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and enhance the digital transformation. The company's software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure across private, hybrid, and public cloud infrastructures; and DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations. It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports. In addition, it offers cloud IT services; and healthcare IT services, such as electronic health records and software implementation, optimization, and extension to community partners, as well as application managed services, and backup and disaster recovery on public cloud. The company primarily serves healthcare delivery organizations, healthcare insurance companies, pharmaceutical and life sciences, biotech companies, and medical device manufacturers. Healthcare Triangle, Inc. was incorporated in 2019 and is based in Pleasanton, California. Healthcare Triangle, Inc. operates as a subsidiary of SecureKloud Technologies, Inc.
IPO date
Oct 01, 2021
Employees
49
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
Income | |||||
Revenues | 33,203 -27.64% | 45,886 30.10% | 35,270 12.54% | ||
Cost of revenue | 37,319 | 52,927 | 39,207 | ||
Unusual Expense (Income) | |||||
NOPBT | (4,116) | (7,041) | (3,937) | ||
NOPBT Margin | |||||
Operating Taxes | 35 | 63 | 24 | ||
Tax Rate | |||||
NOPAT | (4,151) | (7,104) | (3,962) | ||
Net income | (12,339) 28.40% | (9,610) 61.51% | (5,950) -352.82% | ||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | 500 | 5,746 | 1,143,866 | ||
BB yield | -4.31% | -87.03% | -2,147.52% | ||
Debt | |||||
Debt current | 3,429 | 2,412 | 3,454 | ||
Long-term debt | 888 | 176 | |||
Deferred revenue | |||||
Other long-term liabilities | 500 | 2,227 | 2,227 | ||
Net debt | 3,083 | (4) | 1,044 | ||
Cash flow | |||||
Cash from operating activities | (1,612) | (2,600) | (7,293) | ||
CAPEX | (13) | (3,319) | (3,129) | ||
Cash from investing activities | (13) | (3,319) | (7,629) | ||
Cash from financing activities | 1,518 | 5,490 | 15,289 | ||
FCF | (1,443) | (2,373) | (10,829) | ||
Balance | |||||
Cash | 1,234 | 1,341 | 1,770 | ||
Long term investments | 1,075 | 816 | |||
Excess cash | 122 | 822 | |||
Stockholders' equity | (24,905) | (12,568) | (2,664) | ||
Invested Capital | 30,260 | 29,595 | 24,479 | ||
ROIC | |||||
ROCE | |||||
EV | |||||
Common stock shares outstanding | 4,229 | 3,674 | 2,943 | ||
Price | 2.75 52.75% | 1.80 -90.07% | 18.10 | ||
Market cap | 11,608 75.82% | 6,602 -87.60% | 53,264 | ||
EV | 14,691 | 6,598 | 54,308 | ||
EBITDA | 3,116 | (3,667) | (2,516) | ||
EV/EBITDA | 4.71 | ||||
Interest | 968 | 212 | 567 | ||
Interest/NOPBT |